$CRBU

Caribou Biosciences Inc

$CRBU

Caribou Biosciences Inc

Past 12mo:15mentions2voices

All voices2 calls since Nov 2025show all

Loading price chart…

Recent calls

2 calls

@jacobpliethNov 3, 2025 · 8:33 PM

@Sanctuary_Bio @adamfeuerstein This is just another sign that $CRBU floated way ahead of time. These kinds of scientific minutiae (HLA/no HLA, 2+/4+ alleles, young/old donors) should have been sorted in private, in a lab, rather than in the full glare of the public markets.

Open on X

@adamfeuersteinNov 3, 2025 · 12:01 PM

Caribou Biosciences $CRBU said Monday that its off-the-shelf CAR-T therapy induced complete and durable remissions in patients with advanced B-cell lymphoma. The study results, while preliminary, are comparable to benchmarks set by currently approved, patient-specific CAR-T therapies for lymphoma — an achievement that could push the off-the-shelf CAR-T field forward after years of setbacks and broaden access to cell therapy for blood cancers. https://t.co/dh9V7ZChPT

Open on X

About this stock

$CRBU has been mentioned 15 times over the past 12 months by 2 distinct FinTwit voices, with the first mention appearing on November 3, 2025 at 11:05:33 UTC and the most recent on the same day at 21:13:54 UTC. @jacobplieth (@jacobplieth) is the most active voice discussing Caribou Biosciences, accounting for 11 of the 15 mentions, while @adamfeuerstein (@adamfeuerstein ✡️) contributed 4 mentions. The discussion centers on biotech-related topics.

AI-generated from tracked posts · updated Jul 20, 2026